Background illustration for clinical trials search

Paid Clinical Trials Clearwater

Discover 1,424 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Distress Tolerance Treatment for Substance Users

for
Substance Dependence
Location: Tarpon Springs FL
Sponsor: University of South Florida

Sex: All

Age: 18 - 65

Code: NCT01741415

Phase 2, Recruiting

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

for
Idiopathic Pulmonary Fibrosis
Location: St. Petersburg FL, Tampa FL, Brandon FL, Kissimmee FL,
Sponsor: Trevi Therapeutics

Sex: All

Age: 40+

Code: NCT07671911

Phase 3, Recruiting

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

for
Graves Disease
Location: Tampa FL, Fort Myers FL, Palm Beach Gardens FL,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70

Code: NCT07661056

Phase 3, Recruiting

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

for
Geographic Atrophy, Macular Degeneration
Location: St. Petersburg FL, Gainesville FL, Fort Lauderdale FL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 60+

Code: NCT06635148

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

for
Diabetic Macular Edema
Location: St. Petersburg FL, Germantown TN, Lynchburg VA,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07425522

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for
Macular Edema Secondary to Inflammation
Location: St. Petersburg FL, Fort Lauderdale FL, Charleston SC,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06990399

Phase 3, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

for
Macular Edema Secondary to Inflammation
Location: St. Petersburg FL, Fort Lauderdale FL, Charleston SC,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06996080

Phase 3, Recruiting

E-STIM Trial: Comparing the Efficacy of the Empi Select TENS to a Control for the Treatment of Chronic Lower Back Pain

for
Lower Back Pain
Location: St. Petersburg FL, Pensacola FL, Atlanta GA, Reston VA,
Sponsor: Empi, A DJO Company

Sex: All

Age: 18 - 65

Code: NCT00709748

Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: St. Petersburg FL, Tampa FL, Sarasota FL, Mobile AL,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase 3, Recruiting

A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis
Location: St. Petersburg FL, Dothan AL, Rock Hill SC,
Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All

Age: 40+

Code: NCT07516951

Phase 2, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for
Solid Tumors
Location: St. Petersburg FL, Fort Myers FL, West Palm Beach FL,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase 3, Recruiting

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

for
Bronchiectasis
Location: St. Petersburg FL, Winter Park FL, Naples FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07201051

Phase 2, Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

for
Narcolepsy Type 1, Narcolepsy Type 2
Location: St. Petersburg FL, Brandon FL, Orlando FL,
Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 70

Code: NCT07598708

Phase 2, Phase 3, Recruiting

Shield Post-Approval Study Protocol

for
Colo-rectal Cancer
Location: Tampa FL, Delray Beach FL, Tamarac FL, Boca Raton FL,
Sponsor: Guardant Health, Inc.

Sex: All

Age: 45 - 70+

Code: NCT06880055

Recruiting

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

for
Pulmonary Disease, Chronic Obstructive
Location: St. Petersburg FL, New Port Richey FL, Brooksville FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT06961214

Phase 3, Recruiting

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

for
Pulmonary Disease, Chronic Obstructive
Location: Tampa FL, Cape Coral FL, Greenacres City FL, Miami FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT07780656

Phase 3, Recruiting

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

for
Eosinophilic Asthma
Location: Tampa FL, Orlando FL, Loxahatchee Groves FL,
Sponsor: Kymera Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07323654

Phase 2, Recruiting

A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study

for
Asthma (Diagnosis)
Location: Tampa FL, Miami FL, Dallas TX
Sponsor: Kymera Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07677059

Phase 2, Recruiting

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

for
Overweight or Obesity
Location: St. Petersburg FL, Inverness FL, The Villages FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07685808

Phase 2, Recruiting

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

for
Alzheimer Disease, Dementia, Plaque, Amyloid
Location: Tampa FL, New Port Richey FL, Bradenton FL, Clermont FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 55+

Code: NCT07602582

Phase 3, Recruiting